| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |